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Evaluation of Natural Compound IGIB002 for the Anti Asthmatic Activity in a Mouse Model of Asthma
Kavish Ihtisham
All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi 1) To develop certain asthma mimicking features in mice to develop a mouse model of asthma. 2) To evaluate the effect of a natural compound IGIB002 on the above asthmatic features. 3) To examine the side effects of IGIB002.
BALB/c male mice were obtained from National Institute of Nutrition, Hyderabad. Mice 8-10 weeks old weighing 18-22 gms were acclimatized for 1 week under lab conditions. Before starting the experiment mice were sensitized by injecting intraperitoneal 0.2 ml of saline containing 10 mg OVA and 200 mg alum. After 5 days of last IP injection mice were challenged with OVA/ Saline for 5 days. IGIB002 was given right from the first day, 0 to 23rd day once daily. OVA induced PenH was measured on 24th day followed by AHR on the 25th day.
Compound IGIB002 reduced the allergen induced airway constriction, level of IgE, IL-4, IL-5 and IFNgamma. Levels of SGOT, SGPT, creatinine, CPK, Cholesterol, HDL, Protein and Glucose were unaltered, which shows that the compound does not have any adverse effects.
Natural therapies effectively treat asthma and leave the immune system in functionally effective state. In the present study we tested a natural compound IGIB002, and found that it significantly prevented all the above mentioned asthma features. Since we obtained good activity of the compound, we also investigated its side effects and found that the compound had no side effects. Although the data is very preliminary and sample number is very small, the study demonstrated that IGIB002 attenuates asthmatic features and has no side effects and hence can be used as an important natural agent to develop anti-asthmatic drugs for human asthma.
